325 related articles for article (PubMed ID: 10632285)
1. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
[TBL] [Abstract][Full Text] [Related]
2. A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses.
Khan AM; Sasieni P; Singer A
BJOG; 2015 Feb; 122(3):388-94. PubMed ID: 25088393
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort.
Rodríguez AC; Ávila C; Herrero R; Hildesheim A; Sherman ME; Burk RD; Morales J; Alfaro M; Guillén D; Trejos ME; Vargas RM; Torres G; Schiffman M
Int J Cancer; 2017 Apr; 140(8):1926-1934. PubMed ID: 28120391
[TBL] [Abstract][Full Text] [Related]
4. Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice.
Basu P; Muwonge R; Mittal S; Banerjee D; Ghosh I; Panda C; Mandal R; Sankaranarayanan R
J Med Screen; 2016 Jun; 23(2):104-10. PubMed ID: 26566949
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening by visual inspection and HPV testing in Eswatini.
Ginindza TG; Forestier M; Almonte M
Prev Med; 2022 Aug; 161():107144. PubMed ID: 35810934
[TBL] [Abstract][Full Text] [Related]
6. Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
Castle PE; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Wacholder S; Burk RD; Manos MM; Schussler JE; Macomber P; Schiffman M
J Clin Microbiol; 2003 Sep; 41(9):4022-30. PubMed ID: 12958220
[TBL] [Abstract][Full Text] [Related]
7. Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial.
Hu SY; Kreimer AR; Porras C; Guillén D; Alfaro M; Darragh TM; Stoler MH; Villegas LF; Ocampo R; Rodriguez AC; Schiffman M; Tsang SH; Lowy DR; Schiller JT; Schussler J; Quint W; Gail MH; Sampson JN; Hildesheim A; Herrero R;
J Natl Cancer Inst; 2022 Sep; 114(9):1253-1261. PubMed ID: 35640980
[TBL] [Abstract][Full Text] [Related]
8. Significance of concurrent HPV testing with unsatisfactory Papanicolaou test for prediction of follow-up HPV, Papanicolaou test, and biopsy results.
Connelly CF; Collins N; Cimic A; Baskota SU
Am J Clin Pathol; 2023 Nov; 160(5):444-449. PubMed ID: 37418598
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.
Meijer CJ; Berkhof J; Castle PE; Hesselink AT; Franco EL; Ronco G; Arbyn M; Bosch FX; Cuzick J; Dillner J; Heideman DA; Snijders PJ
Int J Cancer; 2009 Feb; 124(3):516-20. PubMed ID: 18973271
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India.
Basu P; Mittal S; Banerjee D; Singh P; Panda C; Dutta S; Mandal R; Das P; Biswas J; Muwonge R; Sankaranarayanan R
Int J Cancer; 2015 Aug; 137(4):859-67. PubMed ID: 25631198
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus testing on self-collected samples to detect high-grade cervical lesions in rural Bhutan: The REACH-Bhutan study.
Clifford GM; Baussano I; Heideman DAM; Tshering S; Choden T; Lazzarato F; Tenet V; Franceschi S; Darragh TM; Tobgay T; Tshomo U
Cancer Med; 2023 May; 12(10):11828-11837. PubMed ID: 36999740
[TBL] [Abstract][Full Text] [Related]
12. Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples.
Martinelli M; Latsuzbaia A; Bonde J; Pedersen H; Iacobone AD; Bottari F; Piana AF; Pietri R; Cocuzza CE; Arbyn M;
Microbiol Spectr; 2024 Mar; 12(3):e0287223. PubMed ID: 38323823
[TBL] [Abstract][Full Text] [Related]
13. Secondary prevention of cervical cancer.
Basu P; Mittal S; Bhadra Vale D; Chami Kharaji Y
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():73-85. PubMed ID: 28988647
[TBL] [Abstract][Full Text] [Related]
14. Clinical Performance of Self-collected Specimen HPV-DNA vs Clinician- collected Specimen HPV-mRNA to Detect High-risk HPV and High-grade Cervical Lesions and Cancer.
Kittisiam T; Chanpanitkitchot S; Tangjitgamol S; Srijaipracharoen S; Manusirivithaya S; Srisomboon J; Termrungruanglert W
Asian Pac J Cancer Prev; 2024 Jan; 25(1):211-217. PubMed ID: 38285786
[TBL] [Abstract][Full Text] [Related]
15. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Saslow D; Solomon D; Lawson HW; Killackey M; Kulasingam SL; Cain J; Garcia FA; Moriarty AT; Waxman AG; Wilbur DC; Wentzensen N; Downs LS; Spitzer M; Moscicki AB; Franco EL; Stoler MH; Schiffman M; Castle PE; Myers ER;
CA Cancer J Clin; 2012; 62(3):147-72. PubMed ID: 22422631
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a compact, rechargeable, magnifying device to triage VIA and HPV positive women in a cervical cancer screening program in rural India.
Basu P; Banerjee D; Mittal S; Mandal R; Ghosh I; Das P; Muwonge R; Biswas J
Cancer Causes Control; 2016 Oct; 27(10):1253-9. PubMed ID: 27581249
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.
Parham GP; Sahasrabuddhe VV; Mwanahamuntu MH; Shepherd BE; Hicks ML; Stringer EM; Vermund SH
Gynecol Oncol; 2006 Dec; 103(3):1017-22. PubMed ID: 16875716
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the performance of algorithms for cervical cancer screening: evidence from the Ludwig-McGill cohort study.
Chevarie-Davis M; Ramanakumar AV; Ferenczy A; Villa LL; Franco EL;
Gynecol Oncol; 2013 Mar; 128(3):415-9. PubMed ID: 23234804
[TBL] [Abstract][Full Text] [Related]
19. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
Fackler MJ; Pleas M; Li Y; Soni A; Xing D; Cope L; Ali S; Van Le Q; Van Nguyen C; Pham HT; Duong LM; Vanden Berg E; Wadee R; Michelow P; Chen WC; Joffe M; Fjeldbo CS; Lyng H; Sukumar S
Clin Epigenetics; 2024 Apr; 16(1):56. PubMed ID: 38643219
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and cervical cancer.
Burd EM
Clin Microbiol Rev; 2003 Jan; 16(1):1-17. PubMed ID: 12525422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
